In this context, approaches to counteract the action of survivin in tumour cells have been proposed with the dual aims of inhibiting tumour growth through promotion of spontaneous apoptosis and of enhancing the tumour cell response to apoptosis-inducing agents (Altieri, 2003b). This evidence concerns the gene BIRC5 and neoplasm.